REQUEST A DEMO
Total
USD $0.00
Search more companies

CB-PHARMA Kft. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: CB-PHARMA Allatgyogyaszati es Kereskedelmi Kft. Profile Updated: August 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

CB-PHARMA Kft. is based in Hungary. The head office is in Budapest. The enterprise operates in the Pharmacies and Drug Stores industry. It was incorporated on December 15, 1993. The total number of employees is currently 3 (2024). From the latest financial highlights, CB-PHARMA Kft. reported a net sales revenue increase of 167.05% in 2023. A growth of 163.48% was recorded in its total assets. The net profit margin of CB-PHARMA Kft. increased by 1.31% in 2023.

Headquarters
Damjanich Janos utca 2.
Budapest; Budapest; Postal Code: 1154

Contact Details: Purchase the CB-PHARMA Kft. report to view the information.

Basic Information
Total Employees:
Purchase the CB-PHARMA Kft. report to view the information.
Outstanding Shares:
Purchase the CB-PHARMA Kft. report to view the information.
Registered Capital:
Purchase the CB-PHARMA Kft. report to view the information.
Incorporation Date:
December 15, 1993
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after CB-PHARMA Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
167.05%
Total operating revenue
160.73%
Operating profit (EBIT)
212.96%
EBITDA
116.48%
Net Profit (Loss) for the Period
238.11%
Total assets
163.48%
Total equity
89.5%
Operating Profit Margin (ROS)
0.97%
Net Profit Margin
1.31%
Return on Equity (ROE)
20.76%
Quick Ratio
0.3%
Cash Ratio
-0.16%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?